Structural and procedural characteristics of international regulatory authorities

被引：0
|
作者：
Anand B. Jain
Annette Mollet
Thomas D. Szucs
机构：
[1] Novo Nordisk Healthcare AG,
来源：
Nature Reviews Drug Discovery | 2017年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：594 / 594
相关论文
共 50 条
  • [41] The Value and Benefits of the International Conference on Harmonisation to Drug Regulatory Authorities: Advancing Harmonization for Better Public Health
    Molzon, J. A.
    Giaquinto, A.
    Lindstrom, L.
    Tominaga, T.
    Ward, M.
    Doerr, P.
    Hunt, L.
    Rago, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (04) : 503 - 512
  • [42] Procedural justice, police legitimacy and public cooperation with legal authorities
    Mesko, Gorazd
    Reisig, Mike D.
    Tankebe, Justice
    REVIJA ZA KRIMINALISTIKO IN KRIMINOLOGIJO, 2012, 63 (02): : 112 - 122
  • [43] PROCEDURAL POWERS OF TAX AUTHORITIES IN THE FIELD OF FISCAL SECURITY PROVISION
    Maslov, Kirill, V
    PRAVOPRIMENENIE-LAW ENFORCEMENT REVIEW, 2019, 3 (01): : 62 - 71
  • [44] The Effects of European Regulatory Networks on the Bureaucratic Autonomy of National Regulatory Authorities
    Danielsen O.A.
    Yesilkagit K.
    Public Organization Review, 2014, 14 (3) : 353 - 371
  • [45] Making the investment case for national regulatory authorities
    Twesigye, Gloria
    Hafner, Tamara
    Guzman, Javier
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2021, 14 (01)
  • [46] THERAPEUTIC PEPTIDES AND PROTEINS - CHALLENGES FOR THE REGULATORY AUTHORITIES
    JEFFCOATE, SL
    JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 1991, 51 (01) : 117 - 119
  • [47] The experience of national regulatory authorities:: The example of Germany
    Börnsen, A
    SERVICES OF GENERAL INTEREST IN THE EU: RECONCILING COMPETITION AND SOCIAL RESPONSIBILITY: DEVELOPMENTS IN TELECOMMUNICATIONS AND POSTAL SERVICES, 1999, : 79 - 86
  • [48] Homoeopathy: not a matter for drug-regulatory authorities
    Garattini, Silvio
    Bertele, Vittorio
    LANCET, 2009, 374 (9701): : 1578 - 1580
  • [49] Making the investment case for national regulatory authorities
    Gloria Twesigye
    Tamara Hafner
    Javier Guzman
    Journal of Pharmaceutical Policy and Practice, 14
  • [50] PUBLIC SERVICE REGULATORY AUTHORITIES IN FRANCE AND COLOMBIA
    Tovar Bermudez, Lizbeth Marisol
    Torres Bueno, Alexander
    NOVUM JUS, 2022, 16 (03): : 457 - 461
12345